All of us have experienced the pervasive impact of the COVID-19 pandemic on our lives. Insurance companies are coping with their own challenges in retaining productivity and managing profitability while maintaining employee health. The Journal of Insurance Medicine has not escaped. Manuscript submissions and the production process have slowed.

As the pandemic evolved, I hoped to publish a few articles about the impact of the pandemic on insurance company medical directors themselves, as well as their changing role within their company value chain. Indeed, there had been expressions of interest in addressing these challenges, but for a long period no manuscripts appeared.

So, I planned to go ahead and publish a traditional issue with several mortality studies, a couple of life expectancy studies, an opinion piece, a couple of case reports, and a set of literature reviews. I was also thinking about...

You do not currently have access to this content.